PMAM
BLFS icon

Picton Mahoney Asset Management’s BioLife Solutions BLFS Stock Holding History

Picton Mahoney Asset Management’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-6,660
Closed -$151K – 864
2022
Q1 		$151K Sell
6,660
-19,240
-74% -$507K 0.01% 671
2021
Q4 		$967K Sell
25,900
-5,605
-18% -$241K 0.02% 600
2021
Q3 		$1.33M Buy
31,505
+1,335
+4% +$64.3K 0.05% 468
2021
Q2 		$1.34M Buy
+30,170
New +$1.06M 0.04% 471

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Picton Mahoney Asset Management's BLFS Position: Q2 2022 in Review

Picton Mahoney Asset Management sold out of BioLife Solutions (BLFS) in Q2 2022, closing a stake of 6,660 shares — an estimated $151K sold.

Picton Mahoney Asset Management first reported a position in BLFS in Q2 2021 and held it in 4 quarters. The position peaked at $1.34M in Q2 2021. 160 funds tracked by Wall St. Rank hold BLFS as of Q2 2022.

  • Picton Mahoney Asset Management reported no remaining BioLife Solutions position as of Q2 2022 after selling out during the quarter.
  • Picton Mahoney Asset Management sold 6,660 BioLife Solutions shares in Q2 2022, an estimated $151K.
  • Picton Mahoney Asset Management first reported a position in BioLife Solutions in Q2 2021 and held it in 4 quarters.
  • Picton Mahoney Asset Management's BioLife Solutions position peaked at $1.34M in Q2 2021.
  • 160 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2022.

Based on Picton Mahoney Asset Management's 13F filing for Q2 2022, filed 8 Aug 2022.